Date of Award
Summer 8-2-2023
Embargo Period
8-5-2028
Document Type
Dissertation
Degree Name
Doctor of Philosophy (PhD)
Department
Molecular and Cellular Biology and Pathobiology
Additional Department
Neuroscience
College
College of Graduate Studies
First Advisor
Bärbel Rohrer
Second Advisor
Hainan Lang
Third Advisor
Judy R. Dubno
Fourth Advisor
Carl Atkinson
Fifth Advisor
Shahid Husain
Sixth Advisor
Robin Muise-Helmericks
Abstract
Dual sensory loss is defined as a combination of age-related vision loss, e.g., age-related macular degeneration (AMD), and age-related hearing loss (ARHL), that co-occurs in people aged >65 years. Dry and wet forms of AMD and ARHL share etiologies such as smoking and complement dysregulation. Controlling the complement alternative pathway (AP) amplification loop is crucial, as it causes the majority of complement activation on cell surfaces and extracellular membranes. AP is inhibited by circulating complement protein factor H (fH). Additionally, natural antibodies (nAbs) binding to neoepitopes on damaged tissues in response to injury can activate complement. Complement effector molecules and nAbs have been shown to be elevated in the subretinal space of wet AMD, smoke-induced ocular damage, and the cochlear tissues of aged mouse models where they activate macrophages and intensify the inflammatory state leading to neurodegeneration. In this project, two well-studied fusion proteins, CR2-fH and B4-scFv-fH, were used to target the inhibitory domain of fH to damaged tissue. The complement receptor 2 (CR2) domain binds to complement fragments deposited on sites of inflammation, and the single chain antibody B4 (B4-scFv) domain binds to modified annexin IV exposed on damaged tissues. Mouse models of neurodegenerative diseases have shown both to be efficacious when administered systemically, locally, and via gene therapy (CR2-fH). Our study suggests that vector-driven CR2-fH and injected B4-scFv-fH localize fH to damaged nerve tissues and mitigate wet AMD and ARHL pathology by reducing macrophage activation and lessening the complement-macrophage inflammatory feedback loop.
Recommended Citation
Parsons, Nathaniel, "Strategies to Control Alternative Pathway Activation in Dual Sensory Loss" (2023). MUSC Theses and Dissertations. 812.
https://medica-musc.researchcommons.org/theses/812
Rights
Copyright is held by the author. All rights reserved.
Included in
Biotechnology Commons, Cell Biology Commons, Genetics Commons, Immunopathology Commons, Immunotherapy Commons, Laboratory and Basic Science Research Commons, Molecular and Cellular Neuroscience Commons, Molecular Genetics Commons